VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia. Acta Haematol. 2018; 140(1):30-39.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Biomarkers, Tumor
Disease-Free Survival
Drug Administration Schedule
Erlotinib Hydrochloride
Fatigue
Female
Humans
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute
Male
Middle Aged
Recurrence
Treatment Outcome
Young Adult
authors with profiles
VARSHA V GANDHI
ZEEV ESTROV
JORGE E CORTES
MARINA KONOPLEVA
ALESSANDRA FERRAJOLI
WILLIAM G WIERDA
BETTY LAMOTHE
YESID ALVARADO
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
NAVEEN PEMMARAJU
HAGOP M KANTARJIAN